OpenAI’s New AI Model Rosalind Could Shave Years Off Drug Discovery. You Probably Can’t Use It

In brief

• OpenAI unveiled GPT-Rosalind to accelerate drug discovery workflows.
• Benchmarks show strong gains, but real-world impact remains constrained .
• Access is tightly restricted amid rising biosecurity concerns.